Science Explorer Interactive view Map
Company · Frederick · ??

Leidos Biomedical Research Inc. (United States)

leidos.com/markets/health/life-sciences/leidos-biomedical-researchROR OpenAlex
World rank, all time
#9,946
of 42,892
Rank in ??
#124
of 1,041
Research works
202
▼ 6% vs 2013–17
Citations
8.4k
41.5 per fractional work
Top-10% rate
32.8%
record average 16.5%
Open access
75%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.24× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 6.49× its world share, 12 worksBiochemistry, Geneti…Immunology and Microbiology: 12.25× its world share, 4 worksImmunology and Micro…Neuroscience: 0.62× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.96× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.65× its world share, 1 worksChemistryComputer Science: 0.17× its world share, 0 worksComputer ScienceEngineering: 0.08× its world share, 0 worksEngineeringEnvironmental Science: 0.34× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.88× its world share, 1 worksMaterials ScienceMathematics: 0.27× its world share, 0 worksMathematicsPhysics and Astronomy: 0.52× its world share, 0 worksPhysics and AstronomyDentistry: 0.60× its world share, 0 worksDentistryMedicine: 1.99× its world share, 14 worksMedicineEconomics, Econometrics and Finance: 0.12× its world share, 0 worksEconomics, Econometr…Psychology: 0.10× its world share, 0 worksPsychologySocial Sciences: 0.01× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 12.2×. Every wedge is a field page.

Which keywords describe research at Leidos Biomedical Research Inc. (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Immune Response, Vaccine, Immunotherapy, Cancer Therapy, Cancer, Immunity, SARS-CoV-2 and Antiretroviral Therapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 21 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Epidemiology3▲ 2.0×28 topics
  2. Cancer2▲ 5.0×21 topics
  3. Immune Response2▲ 11×9 topics
  4. Vaccine2▲ 15×6 topics
  5. Cancer Therapy2▲ 9.8×13 topics
  6. Immunotherapy2▲ 8.0×14 topics
  7. Immunity2▲ 13×5 topics
  8. Pandemic2▲ 4.3×4 topics
  9. SARS-CoV-22▲ 15×4 topics
  10. Antiretroviral Therapy2▲ 25×6 topics
  11. Inflammation2▲ 2.1×22 topics
  12. ACE2 Receptor1▲ 16×2 topics
  13. Cancer Immunotherapy1▲ 26×3 topics
  14. Innate Immunity1▲ 11×6 topics
  15. Machine Learning1◆ 1.12×7 topics
  16. Tumor Microenvironment1▲ 8.1×7 topics
  17. Gene Expression1▲ 5.6×9 topics
  18. Chemotherapy1▲ 4.3×9 topics
  19. Mutation1▲ 17×3 topics
  20. Antigen Presentation1▲ 33×2 topics
  21. Genetic Mutations1▲ 6.6×9 topics

Which research topics does Leidos Biomedical Research Inc. (United States) publish most on?

By volume in 2022–2025: HIV Research and Treatment, SARS-CoV-2 and COVID-19 Research, Immunotherapy and Immune Responses and Immune Cell Function and Interaction.

HIV Research and Treatment1HIV Research and Treatment: 1 fractional worksSARS-CoV-2 and COVID-19 …1SARS-CoV-2 and COVID-19 Research: 1 fractional worksImmunotherapy and Immune Responses: 1 fractional worksImmune Cell Function and…1Immune Cell Function and Interaction: 1 fractional worksCancer Genomics and Diag…1Cancer Genomics and Diagnostics: 1 fractional worksRNA and protein synthesis mechanisms: 1 fractional worksCOVID-19 Clinical Research Studies: 1 fractional worksProtein Kinase Regulatio…1Protein Kinase Regulation and GTPase Signaling: 1 fractional worksCAR-T cell therapy research: 1 fractional worksT-cell and B-cell Immunology: 0 fractional works
VirologyInfectious DiseasesImmunologyCancer Research2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 HIV Research and Treatment Virology 1 works
  2. 2 SARS-CoV-2 and COVID-19 Research Infectious Diseases 1 works
  3. 3 Immunotherapy and Immune Responses Immunology 1 works
  4. 4 Immune Cell Function and Interaction Immunology 1 works
  5. 5 Cancer Genomics and Diagnostics Cancer Research 1 works
  6. 6 RNA and protein synthesis mechanisms Molecular Biology 1 works
  7. 7 COVID-19 Clinical Research Studies Infectious Diseases 1 works
  8. 8 Protein Kinase Regulation and GTPase Signaling Molecular Biology 1 works
  9. 9 CAR-T cell therapy research Oncology 1 works
  10. 10 T-cell and B-cell Immunology Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available75.0%not open25.0%

World: 28% of research is openly available.

with international co-authors30.6%domestic only69.4%

World: 19% is written across borders.

How has Leidos Biomedical Research Inc. (United States)'s research output changed?

Output in 2018–2022 was 6% lower than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.